Are all 5-HT3 receptor antagonists the same?
- 31 December 1992
- journal article
- research article
- Published by Elsevier in European Journal Of Cancer
- Vol. 28, S2-S6
- https://doi.org/10.1016/0959-8049(92)90628-f
Abstract
No abstract availableKeywords
This publication has 13 references indexed in Scilit:
- Preliminary evidence for the involvement of the putative 5-HT4 receptor in zacopride- and copper sulphate-induced vomiting in the ferretEuropean Journal of Pharmacology, 1991
- Studies on the emetic and antiemetic properties of zacopride and its enantiomersEuropean Journal of Pharmacology, 1991
- Granisetron (BRL 43694) in the treatment of cytostatic drug-induced emesis: A summaryCancer Treatment Reviews, 1990
- The anti-emetic action of the novel 5-HT3 receptor antagonist L-683,877 in the ferretEuropean Journal of Pharmacology, 1990
- The concept of selectivity in 5-HT receptor researchEuropean Journal of Pharmacology: Molecular Pharmacology, 1990
- Emetic activity of zacopride in ferrets and its antagonism by pharmacological agentsEuropean Journal of Pharmacology, 1990
- The abdominal visceral innervation and the emetic reflex: pathways, pharmacology, and plasticityCanadian Journal of Physiology and Pharmacology, 1990
- Neuropharmacology of emesis induced by anti-cancer therapyTrends in Pharmacological Sciences, 1988
- Pharmacological properties of GR38032F, a novel antagonist at 5‐HT3 receptorsBritish Journal of Pharmacology, 1988
- Inhibition of cisplatin‐induced vomiting by selective 5‐hydroxytryptamine M‐receptor antagonismBritish Journal of Pharmacology, 1986